← FDA Drug Approvals (Drugs@FDA)

AZACITIDINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2020-11-02

Drug application

FDA Application #
ANDA212128
Application type
Abbreviated New Drug Application (Generic)
Brand name
AZACITIDINE
Generic name
AZACITIDINE
Active ingredients
AZACITIDINE
Dosage form
POWDER
Route
INTRAVENOUS, SUBCUTANEOUS
Marketing status
Prescription
Sponsor
MEITHEAL
Manufacturer
Meitheal Pharmaceuticals Inc.
First approval
2020-11-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown